Impact of complete surgical staging on survival of patients with early-stage (FIGO I or II) ovarian cancer: Data from the Cote d'Or Registry of Gynecological Cancers from 1998 to 2015.

Date publication

février 2023

Journal

Bulletin du cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ARNOULD Laurent , Dr DABAKUYO-YONLI Sandrine , Dr FAVIER Laure , Dr BENGRINE-LEFEVRE Leila , Dr FUMET Jean-David , Dr MAMGUEM KAMGA Ariane

Tous les auteurs :
Michel E, Mamguem Kamga A, Amet A, Padeano MM, Fumet JD, Favier L, Bengrine Lefevre L, Beltjens F, Arnould L, Dabakuyo S, Costaz H

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36805207

Résumé

Early-stage ovarian cancer represents 20 to 33% of all ovarian cancers and is thus quite rare in France, with around 1200 new cases per year. No study to date has convincingly demonstrated the utility of lymphadenectomy in early-stage ovarian cancer. We sought to evaluate the impact on overall survival of complete surgical staging in patients management for FIGO stage I and II ovarian cancer.

Mots clés

Early stage, Lymphadenectomy, Ovarian Cancer, Surgery

Référence

Bull Cancer. 2023 02 17;: